» Authors » R Pytlik

R Pytlik

Explore the profile of R Pytlik including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 36
Citations 145
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kopackova M, Beranek P, Bydzovska I, Pytlik R, Soukup J, Mrhalova M
Ceska Gynekol . 2018 Mar; 83(1):45-49. PMID: 29510639
Objective: Presentation of a rare finding non-Hodgkin´s B-lymphoma of the ovary in a patient during caesarean section. Design: Case report. Settings: Department of Obstetrics and Gynaecology, Regional Hospital Liberec, a.s.;...
2.
Pytlik R, Rentsch C, Soukup T, Novotny L, Rentsch B, Kanderova V, et al.
Physiol Res . 2016 Oct; 66(1):113-123. PMID: 27782744
To evaluate the preclinical efficacy and safety of human mesenchymal stem cells (hMSC) rapidly expanded in growth medium for clinical use with human serum and recombinant growth factors, we conducted...
3.
Sykorova A, Pytlik R, Mocikova H, Belada D, Benesova K, Papajik T, et al.
Klin Onkol . 2016 Aug; 29(4):295-302. PMID: 27534788
Background: Recent advances in the use of the imaging modalities, especially PET/CT, and their utilization for determining clinical stage (CS) and assessment treatment response (TR) in malignant lymphomas, along with...
4.
Pohlreich D, Vackova B, Pytlik R, Trnkova M, Trneny M
Klin Onkol . 2015 Oct; 28 Suppl 3:3S95-104. PMID: 26489508
Despite achieving promising treatment results in patients with lymphoma, there is still a significant proportion of patients who relapse or have refractory disease. Salvage therapy followed by high dose treatment...
5.
Pytlik R, Trneny M
Klin Onkol . 2015 Oct; 28 Suppl 3:3S64-72. PMID: 26489504
Background: Diffuse large B -cell lymphoma is a common label for a number of clinico pathological entities, which differ in molecular pathogenesis, clinical presentation and prognosis. Exact correlation between clinico ...
6.
Trneny M, Klener Jr P, Pytlik R
Klin Onkol . 2015 Oct; 28 Suppl 3:3S55-63. PMID: 26489503
This review summarizes the key steps on the way to understanding lymphoma biology and management. The history of lymphomas started in 1832 when Thomas Hodgkin first presented lymphomas. Classification of...
7.
Blijlevens N, de Chateau M, Krivan G, Rabitsch W, Szomor A, Pytlik R, et al.
Bone Marrow Transplant . 2012 Dec; 48(7):966-71. PMID: 23241739
This randomized-controlled trial studied the efficacy of palifermin in a chemotherapy-only, high-dose Melphalan (HDM) transplant setting, to reduce oral mucositis (OM) and its sequelae measured by patient-reported outcomes (PRO) and...
8.
Benesova K, Forsterova K, Votavova H, Campr V, Stritesky J, Velenska Z, et al.
Neoplasma . 2012 Oct; 60(1):68-73. PMID: 23067219
Diffuse large B-cell lymphoma (DLBCL) consists of at least two biologically and pathogenetically different subtypes, the germinal centre B-cell (GCB) and the activated B cell type (ABC). It has been...
9.
Stehlik D, Pytlik R, Rychtrmocova H, Kideryova L, Vesela R, Kopecny Z, et al.
Folia Biol (Praha) . 2012 Aug; 58(3):106-14. PMID: 22849860
We have studied a rapid cultivation method for human mesenchymal stromal cells based on CellGroTM medium and human serum, supplemented with insulin, ascorbic acid, dexamethasone, epidermal growth factor, platelet-derived growth...
10.
Stehlik D, Pytlik R, Rychtrmocova H, Vesela R, Kopecny Z, Trc T
Acta Chir Orthop Traumatol Cech . 2012 Jan; 78(6):537-43. PMID: 22217407
Purpose Of The Study: The aim of this study was to compare the standard laboratory method of cultivation of mesenchymal multipotent stromal cells (MSC) and a novel technique of rapid...